Oncolytics Biotech Inc. Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Oncolytics Biotech Inc. is a biotechnology research company based in San Diego, California, focused on oncology. It is developing pelareorep, an intravenously delivered immunotherapy designed to trigger both innate and adaptive immune responses while undermining tumor defenses, with the aim of enhancing the immune system's capacity to attack cancer and making tumors more responsive to diverse cancer treatments. This places the company within the field of cancer immunotherapy development. The company targets oncology researchers, clinicians, and patients seeking new immunotherapeutic options to complement existing therapies. In 2026, Oncolytics launched the randomized Phase 2 REO-033 trial evaluating pelareorep in ras-mutant MSS metastatic colorectal cancer.